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Valorisation 1034 
 1035 
The medical, societal and economic consequences of cardiovascular disease 1036 
(CVD) combined with the growing world population over the age of 60 years 1037 
requires multilevel assessments and multidimensional solutions. The World Health 1038 
Organization (WHO) has estimated that by the year 2050 the world population 1039 
aged 60 or over will be two billion. Human ageing is associated with an increased 1040 
risk of cardiovascular problems and effective intervention strategies are highly 1041 
needed for the prevention or delay of CVD. The research described in the present 1042 
dissertation focused on three well-defined intervention studies and two meta- 1043 
analyses of intervention trials, which were specially designed to assess the specific 1044 
effects of various dietary factors and weight loss on vascular function markers 1045 
predicting the risk for CVD. We provided further evidence that dietary changes 1046 
improve cardiovascular health based on beneficial effects on vascular endothelial 1047 
function and arterial stiffness. Besides the scientific value of the research 1048 
described in this dissertation, the study findings can also be presented in terms of 1049 
societal and economic relevance, which is known as valorisation. Valorisation has 1050 
been defined by the Dutch National Valorisation Commission as “the process of 1051 
creating value from knowledge by making knowledge suitable and/or available for 1052 
societal and/or economic use, and by translating that knowledge into competitive 1053 
products, services, processes and commercial activities”. In other words: “How can 1054 
the findings described in this thesis be translated into practice?”. The societal and 1055 
economic relevance of these findings will be first addressed. The next question 1056 
that needs to be addressed is how the generated scientific knowledge can be 1057 
translated into practice.  1058 
 1059 
 1060 
Societal and economic relevance 1061 
 1062 
Various vascular function markers are associated with future cardiovascular events 1063 
and can also be used to demonstrate CVD benefits. We found that a single dose of 1064 
beetroot juice improved the postprandial impairment in flow-mediated vasodilation 1065 
of the brachial artery (FMD) after consumption of a mixed meal [reported in 1066 
chapter 3]. In our meta-analysis described in chapter 5, it was estimated that 1067 
each 10 kg decrease in body weight was associated with an increase of about 1% 1068 
in FMD. Results from prospective epidemiological studies have suggested that the 1069 
risk of CVD decreases by 8% when FMD increases by 1% [1]. In abdominally 1070 
obese men, diet-induced weight-loss tended to decrease carotid-to-femoral pulse 1071 
wave velocity (PWVc-f) by 0.5 m/s [chapter 6]. A decrease of this magnitude at the 1072 
population level would lead to a 7% risk reduction of CVD [2]. Furthermore, as 1073 
reported in chapter 7, long-term magnesium supplementation in overweight and 1074 
slightly obese adults improved PWVc-f as compared with placebo by 1 m/s, which 1075 
has been related with a 14% decrease in the risk to develop CVD [2]. The 1076 
relevance of these nutritional interventions in promoting public health can thus be 1077 
found in the prevention of CVD in the large part of the population that is at 1078 
increased cardiovascular risk, but not yet diagnosed with disease or under medical 1079 
treatment. In addition, high-risk patients such as subjects already diagnosed with 1080 
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CVD may also benefit from these intervention strategies, but this warrants further 1081 
studies. 1082 
 Identifying effective intervention strategies to prevent or postpone 1083 
conditions such as CVD associated with human aging will also have an enormous 1084 
economic impact. In fact, nutritional interventions described in the present 1085 
dissertation, such as oral magnesium supplementation [chapter 7], which can be 1086 
easily achieved at low costs, could scale down medical costs, revalidation and 1087 
medication, and would therefore be of significant economic relevance. This would 1088 
also have a great societal impact, since CVD is the leading cause of death 1089 
worldwide [3]. However, potential risks that may be associated with the 1090 
consumption of dietary components described in this dissertation should also be 1091 
kept in mind. For instance, concern has been raised about potential adverse 1092 
effects of vitamin E supplementation. One meta-analysis indeed concluded that 1093 
high-dose vitamin E supplementation may increase all-cause mortality in trials 1094 
supplying daily doses > 400 IU, that involved adults with chronic diseases [4]. In 1095 
another thorough meta-analysis, vitamin E given singly or in combination with other 1096 
antioxidant supplements was also found to increase mortality in randomized 1097 
primary and secondary prevention trials when trials with low methodological quality 1098 
were excluded [5]. 1099 
 The various vascular function measurements described in this dissertation 1100 
may also function as future screening tools to determine the specific components, 1101 
either from nutritional or pharmacological origin, that will be beneficial to reduce the 1102 
risk to develop CVD. Measurement of these validated vascular markers may also 1103 
give physicians the opportunity in the future to early diagnose and follow the 1104 
progression of cardiovascular complications. In fact, PWVc-f has already been 1105 
depicted as a promising future tool for cardiovascular risk prediction in clinical 1106 
practice [6, 7]. This is of the great importance, as it has been shown that various 1107 
treatments are more effective if they are given early in the disease process. 1108 
Furthermore, more information on the development and natural progression of 1109 
age-related conditions such as CVD will be provided. Overall, the present thesis 1110 
provides further data on the sensitivity of various vascular markers to diet-induced 1111 
changes. From industrial, academic and public health perspective, these results 1112 
may be of great relevance as vascular dysfunction is a key mechanism whereby a 1113 
healthy diet and healthy lifestyle improve cardiovascular health [8]. 1114 
 1115 
 1116 
Translation into practice  1117 
 1118 
The results described in this thesis have been presented at national and 1119 
international conferences to colleagues inside and outside the field with the 1120 
purpose to increase the awareness of the medical, societal and economic 1121 
consequences of CVD and to highlight the potential impact of diet and weight loss. 1122 
Results have also been discussed with experts for possible explanations or 1123 
innovative ways to look at the data. For instance, experts of the industrial partners 1124 
within this project have contributed to the described research projects through 1125 
regular discussions at tri-annual expert meetings.  Moreover, research findings 1126 
have been published or submitted to international peer-reviewed scientific journals 1127 
in the categories “nutrition and dietetics” and “peripheral vascular disease”. 1128 
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Published research data are therefore accessible to scientists worldwide, and will 1129 
drive other research groups for further investigation with the purpose to further 1130 
broaden current knowledge. 1131 
 The research described in the present thesis was funded by research 1132 
grant CH-001 from the Top Institute of Food and Nutrition (TIFN). TIFN is a public- 1133 
private partnership between knowledge institutes, industry and government 1134 
conducting strategic research in food and nutrition. Further, magnesium and 1135 
placebo capsules were kindly provided by Laboratorium Medisan B.V. 1136 
(Heerenveen, The Netherlands). These interactions and cooperation’s are crucial 1137 
for the optimal valorisation of findings extracted from scientific research. In fact, 1138 
scientists have a good insight into existing knowledge from scientific publications 1139 
and they can use that knowledge to design promising trials. Scientists know how to 1140 
perform well-designed intervention studies and academia have state-of-the-art 1141 
facilities to investigate health effects of the most promising products. On the other 1142 
hand, industries focus on the innovative and practical use of research, and the 1143 
translation into products that can be marketed, while the Dutch government 1144 
supports science and industry to transfer scientific knowledge for the benefit of 1145 
society and the economy. Close collaborations between these partners will have 1146 
societal and economic impact as they facilitate both the translation of research 1147 
findings into commercial products that may lead to an improvement in quality of life 1148 
and the application of generated knowledge for governmental policy-making. 1149 
 Research findings reported in the present dissertation should be confirmed 1150 
in additional studies. The effects of dietary interventions may also differ between 1151 
target groups. While we focused on the large part of the population that is at 1152 
increased cardiovascular risk, but not yet diagnosed with disease or under drug 1153 
treatment, future research should now broaden its focus on different target groups 1154 
(e.g. subjects with the metabolic syndrome or CVD patients). Only when results 1155 
are confirmed in several independent scientific trials, these study findings can be 1156 
considered univocal. The generated scientific knowledge can be used by different 1157 
policy makers. One group may be the Health Council of the Netherlands, which is 1158 
an independent scientific advisory body informing the Dutch government and 1159 
parliament on public health. Health agencies such as the Netherlands Nutrition 1160 
Centre (Voedingscentrum) are valuable in providing scientific evidence-based 1161 
information on healthy and safe food to the Dutch population. In addition, the 1162 
European Food and Safety Authority (EFSA) is the agency of the European Union 1163 
that provides highly valuable scientific advice on the use of foods and food 1164 
components. EFSA protects European consumers from scientifically unfunded 1165 
advice regarding healthy nutrition, which has a negative impact on nutritional 1166 
science and also threatens the credibility of nutritional scientists. 1167 
 1168 
 1169 
 1170 
 1171 
 1172 
 1173 
 1174 
 1175 
  1176 
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